CNSA 24th Annual Congress |16-18 Jun 2022 | Brisbane Convention and Exhibition Centre | Cancer Nursing Workforce, Strong, Skilled & Sprcialised

About the Breakfast Sessions

Breakfast sessions are available for all delegates to attend (excluding exhibitors) and spaces are limited and strictly on a first come first serve basis. A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence. 

Please click on the links below for more information on the breakfast topics.   In order to attend the breakfast sessions, you will be required to indicate your attendance as part of your registration form.


Thursday 16 June

Breakfast Session 1 - Supported by  Maurice Blackburn Lawyers- Topic TBC

Breakfast Session 2 - Supported by  GSK - Nursing Ovarian Cancer Patients: How to help women get the most from their maintenance therapy

Breakfast Session 3 - Supported by Merck - ONCADERM Education: Identify and manage cutaneous reactions in patients being treated with EGFR inhibitors

Friday 17 June

Breakfast Session 1 - Brought to you by the MSD and Eisai Strategic Collaboration - Renal Cell Carcinoma: A focus on managing your patients on IO + TKI combination therapy

Breakfast Session 2 - Supported by Novartis - Metastatic Breast Cancer: Helping patients navigate the CDK4/6i discussion

Saturday 18 June

Breakfast Session 1 - Supported by AstraZeneca - Changing Treatment Paradigms in HER2-positive Metastatic Breast Cancer and the Role of ENHERTU (trastuzumab-deruxtecan)

Breakfast Session 2 - Supported by Gilead Sciences - See Beyond the Negative: Advances in the Treatment of TNBC


Thursday 16 June

Breakfast Session 1

MauriceBlackburn

Title: Update on Dust and Occupational Cancers and Where to From Here

Time: 0745 - 0915 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.45am - 8.15am). This will be served outside the meeting room.

Presenter: to be confirmed

Description: to be confirmed

 

Breakfast Session 2

GSK

Title: Nursing Ovarian Cancer Patients: How to help women get the most from their maintenance therapy

Time: 0745 - 0915 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.45am - 8.15am). This will be served outside the meeting room.

Presenters: Anne Mellon, Dr Niara Oliveira and Susie O'Keefe

Description: click here to download the flyer

 

Breakfast Session 3

Title: ONCADERM Education: Identify and manage cutaneous reactions in patients being treated with EGFR inhibitors.

Time: 0715 - 0915 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.15am - 7.45am). This will be served outside the meeting room.

Presenter: Professor Pablo Fernández-Peñas

Description: 

The ONCADERM program aims to provide structured education to assist with the prevention, early identification and optimal management of cutaneous reactions associated with EGFR inhibitor therapy. 

Learning Outcomes: 

  • Understand the mechanism of action of how the EGFR inhibitor affects the structure and function of the skin
  • Recognise and describe the various cutaneous reactions that occur in patients being treated with EGFR inhibitors
  • Follow general management pathways for treating cutaneous reactions associated with EGFR inhibitor treatment

Friday 17 June

Breakfast Session 1

Title: Renal Cell Carcinoma: A focus on managing your patients on IO + TKI combination therapy

Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.

Presenter: Dr Niara Oliveira, Medical Oncologist 

Description: 

Learning outcomes:

  • Review key facts about advanced renal cell carcinoma (RCC)
  • Review the efficacy and safety considerations of a first line IO+TKI combination therapy
  • Discuss monitoring and management of adverse reactions associated with the IO+TKI combination therapy

 


Breakfast Session 2

Title: Metastatic Breast Cancer: Helping patients navigate the CDK4/6i discussion

Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.

Presenters: Dr Michelle Morris

Description: to be confirmed

 

Saturday 18 June


Breakfast Session 1

Title: Changing Treatment Paradigms in HER2-positive Metastatic Breast Cancer and the Role of ENHERTU (trastuzumab-deruxtecan)

Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.

Presenters: to be confirmed

Description: to be confirmed


Breakfast Session 2

Title: See Beyond the Negative: Advances in the Treatment of TNBC

Time: 0730 - 0830 - A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.00am - 7.30am). This will be served outside the meeting room.

Presenters: to be confirmed

Description: to be confirmed